
Sign up to save your podcasts
Or


A company called Ambrosia Health signed up about 150 patients for a novel anti-aging procedure: young blood plasma transfusions. The only problem was the FDA. This week on Decrypted, the story of a startup that claimed it could restore lost youth with young people's blood. We’ll hear from a patient who got the treatment, the researchers who say it endangered patients, and the scientists who believe the idea isn’t as crazy as it seems.
See omnystudio.com/listener for privacy information.
By Bloomberg4.5
965965 ratings
A company called Ambrosia Health signed up about 150 patients for a novel anti-aging procedure: young blood plasma transfusions. The only problem was the FDA. This week on Decrypted, the story of a startup that claimed it could restore lost youth with young people's blood. We’ll hear from a patient who got the treatment, the researchers who say it endangered patients, and the scientists who believe the idea isn’t as crazy as it seems.
See omnystudio.com/listener for privacy information.

534 Listeners

4,340 Listeners

407 Listeners

2,166 Listeners

1,866 Listeners

424 Listeners

355 Listeners

1,632 Listeners

1,086 Listeners

339 Listeners

3,987 Listeners

1,448 Listeners

192 Listeners

67 Listeners

31 Listeners

4 Listeners

155 Listeners

58 Listeners

232 Listeners

229 Listeners

61 Listeners

63 Listeners

147 Listeners

83 Listeners

381 Listeners

22 Listeners

12 Listeners

21 Listeners

7 Listeners

2 Listeners

76 Listeners